Membranous nephropathy in an HIV-positive patient complicated with hepatitis B virus infection

Clinical and Experimental Nephrology

Volumn 15, Issue 5, 2011, Pages 769-773

  Numata, Akihiko ^a   Akimoto, Tetsu ^a   Toshima, Masaki ^a   Iwazu, Yoshitaka ^a   Otani, Naoko ^a   Miki, Takuya ^a   Sugase, Taro ^a   Saito, Osamu ^a   Hamano, Yoshitomo ^a   Takemoto, Fumi ^a   Ueda, Yoshihiko ^b   Muto, Shigeaki ^a   Kusano, Eiji ^a  

^a JICHI MEDICAL UNIVERSITY   (Japan)

^b DOKKYO MEDICAL UNIVERSITY   (Japan)

Author keywords

HAART; HBV; HBV reactivation; HIV; Membranous nephropathy

Indexed keywords

DIURETIC AGENT; EFAVIRENZ; EMTRICITABINE; HEPATITIS B ANTIBODY; HEPATITIS B CORE ANTIBODY; HEPATITIS B SURFACE ANTIGEN; HEPATITIS B(E) ANTIBODY; HEPATITIS B(E) ANTIGEN; IMMUNOGLOBULIN G; PREDNISOLONE; TENOFOVIR DISOPROXIL; VIRUS DNA; VIRUS RNA;

ADULT; ARTICLE; BLOOD PRESSURE MEASUREMENT; BREATHING RATE; CASE REPORT; CD4 LYMPHOCYTE COUNT; CLINICAL FEATURE; CREATININE CLEARANCE; DISEASE ASSOCIATION; DISEASE CLASSIFICATION; DRUG EFFICACY; HEPATITIS B; HEPATITIS B VIRUS; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; HUMAN TISSUE; IMMUNOFLUORESCENCE TEST; IMMUNOHISTOCHEMISTRY; KIDNEY BIOPSY; KIDNEY PARENCHYMA; MALE; MEMBRANOUS GLOMERULONEPHRITIS; MOLECULAR PATHOLOGY; OXYGEN SATURATION; PHYSICAL EXAMINATION; POLYMERASE CHAIN REACTION; PROTEINURIA; PULSE RATE; VIRUS LOAD; VIRUS PATHOGENESIS;

ADENINE; ADULT; ANTI-HIV AGENTS; ANTIRETROVIRAL THERAPY, HIGHLY ACTIVE; DEOXYCYTIDINE; GLOMERULONEPHRITIS, MEMBRANOUS; HEPATITIS B; HIV INFECTIONS; HUMANS; MALE; NEPHROTIC SYNDROME; PHOSPHONIC ACIDS; PREDNISOLONE;

EID: 80755153323     PISSN: 13421751     EISSN: 14377799     Source Type: Journal    
DOI: 10.1007/s10157-011-0477-2     Document Type: Article

References (23)

1. E Boix F Rivera CM Gil J Perez-Contreras J Olivares 2000 Steroid-responsive nephrotic syndrome with minimal-change disease and IgA deposits in a HIV-infected patient Nephrol Dial Transplant 15 412 414 10692530 10.1093/ndt/15.3.412 1:STN:280:DC%2BD3c7lvFSnsg%3D%3D (Pubitemid 30116479)
2. PE Klotman 1999 HIV-associated nephropathy Kidney Int 56 1161 1176 10469389 10.1046/j.1523-1755.1999.00748.x 1:STN:280:DyaK1MzpvVGmsg%3D%3D (Pubitemid 29411749)
3. IL Guerra AA Abraham PL Kimmel SG Sabnis TT Antonovych 1987 Nephrotic syndrome associated with chronic persistent hepatitis B in an HIV antibody positive patients Am J Kidney Dis 5 385 388 (Pubitemid 17161694)
4. JM Schectman PL Kimmel 1991 Remission of hepatitis B-associated membranous glomerulonephritis in human immunodeficiency virus infection Am J Kidney Dis 17 716 718 2042656 1:STN:280:DyaK3M3ltlKiuw%3D%3D
5. T Akimoto T Otake A Tanaka H Takahashi T Higashizawa M Inoue, et al. 2011 Steroid treatment in patients with membranous nephropathy and hepatitis B virus surface antigenemia: a report of two cases Clin Exp Nephrol 15 289 293 21170566 10.1007/s10157-010-0391-z
6. Schwartz MM. Membranous nephropathy. In: Jennete JC, Olson JL, Schwartz MM, Silvia FG, editors. Heptinstall's pathology of the kidney. 6th ed. Philadelphia: Lippincott Williams & Wilkins; 2007. p. 205-51.
7. JA Jefferson WG Couser 2003 Therapy of membranous nephropathy associated with malignancy and secondary causes Semin Nephrol 23 400 405 12923729 10.1016/S0270-9295(03)00055-X (Pubitemid 37022044)
8. J Mattana FP Siegal E Schwarzwald L Molho RT Sankaran R Gooneratne, et al. 1997 AIDS-associated membranous nephropathy with advanced renal failure: response to prednisone Am J Kidney Dis 30 116 119 9214410 10.1016/S0272-6386(97) 90573-4 1:STN:280:DyaK2szlslSmuw%3D%3D (Pubitemid 27284383)
9. R Bhimma HM Coovadia 2004 Hepatitis B virus-associated nephropathy Am J Nephrol 24 198 211 14988643 10.1159/000077065 1:CAS:528:DC%2BD2cXivVSjsL0%3D (Pubitemid 38456630)
10. TW Chuang CH Hung SC Huang CM Lee 2007 Complete remission of nephrotic syndrome of hepatitis B virus-associated membranous glomerulopathy after lamivudine monotherapy J Formos Med Assoc 106 869 873 17964968 10.1016/S0929-6646(08)60054-6
11. K Koike Y Kikuchi M Kato J Takamatsu Y Shintani T Tsutsumi, et al. 2008 Prevalence of hepatitis B virus infection in Japanese patients with HIV Hepatol Res 38 310 314 17877726 10.1111/j.1872-034X.2007.00263.x (Pubitemid 351193960)
12. RM Lascar AR Lopes RJ Gilson C Dunn R Johnstone A Copas, et al. 2005 Effect of HIV infection and antiretroviral therapy on hepatitis B virus (HBV)-specific T cell responses in patients who have resolved HBV infection J Infect Dis 191 1169 1177 15747254 10.1086/428502 1:CAS:528:DC%2BD2MXjtFyhsbY%3D (Pubitemid 40404377)
13. DW Notermans NG Pakker D Hamann NA Foudraine RH Kauffmann PL Meenhorst, et al. 1999 Immune reconstitution after 2 years of successful potent antiretroviral therapy in previously untreated human immunodeficiency virus type 1-infected adults J Infect Dis 180 1050 1056 10479130 10.1086/315013 1:CAS:528:DyaK1MXms1yqsb8%3D (Pubitemid 30070186)
14. GJ Dore DA Cooper AL Pozniak E DeJesus L Zhong MD Miller, et al. 2004 Efficacy of tenofovir disoproxil fumarate in antiretroviral therapy-naive and -experienced patients coinfected with HIV-1 and hepatitis B virus J Infect Dis 189 1185 1192 15031786 10.1086/380398 1:CAS:528:DC%2BD2cXjsleqs7o%3D (Pubitemid 38457242)
15. SI Gan SM Devlin NW Scott-Douglas KW Burak 2005 Lamivudine for the treatment of membranous glomerulopathy secondary to chronic hepatitis B infection Can J Gastroenterol 19 625 629 16247526 1:STN:280: DC%2BD2MrmvV2ksA%3D%3D (Pubitemid 41723288)
16. C Okuse H Yotsuyanagi H Yamada H Ikeda H Takahashi M Suzuki, et al. 2006 Successful treatment of hepatitis B virus associated membranous nephropathy with lamivudine Clin Nephrol 65 53 56 16429843 1:STN:280:DC%2BD28%2FktFyqsQ%3D%3D (Pubitemid 43091696)
17. N Kannaan Y Horsmans E Goffin 2006 Lamivudine for nephrotic syndrome related to hepatitis B virus (HBV) infection Clin Nephrol 65 208 210 (Pubitemid 43338000)
18. LH Calabrese NN Zein D Vassilopoulos 2006 Hepatitis B virus (HBV) reactivation with immunosuppressive therapy in rheumatic diseases: assessment and preventive strategies Ann Rheum Dis 65 983 989 16627542 10.1136/ard.2005. 043257 1:CAS:528:DC%2BD28XosFahur4%3D (Pubitemid 44133258)
19. G Lalazar D Rund D Shouval 2007 Screening, prevention and treatment of viral hepatitis B reactivation in patients with haematological malignancies Br J Haematol 136 699 712 17338776 10.1111/j.1365-2141.2006.06465.x 1:CAS:528:DC%2BD2sXjvFWmtb0%3D
20. CK Chou LH Wang HM Lin CW Chi 1992 Glucocorticoid stimulates hepatitis B viral gene expression in cultured human hepatoma cells Hepatology 16 13 18 1319949 10.1002/hep.1840160104 1:CAS:528:DyaK38Xks1ehtbw%3D
21. MC Smith R Pawar JT Carey RC Graham GH Jacobs A Menon, et al. 1994 Effect of corticosteroid therapy on human immunodeficiency virus-associated nephropathy Am J Med 97 145 151 8059780 10.1016/0002-9343(94)90024-8 1:CAS:528:DyaK2MXosFCqtLg%3D (Pubitemid 24250674)
22. ES Herman PE Klotman 2003 HIV-associated nephropathy: epidemiology, pathogenesis, and treatment Semin Nephrol 23 200 208 12704580 10.1053/snep.2003.50018 (Pubitemid 36397102)
23. T Masuda T Akimoto Y Ando T Kobayashi D Meguro S Muto, et al. 2008 Changes in the urinary excretion of β2-microglobulin (β2MG) and N-acetyl-β-d-glucosaminidase (NAG) during treatment for lupus nephritis Intern Med 47 287 290 18277031 10.2169/internalmedicine.47.0464 (Pubitemid 351377292)